Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matti Aapro

Showing results (81-90 of 237) with videos related to

Pageof 24
Sort By:
Breast (Edinburgh, Scotland)|March 13, 2017
Efficacy of NEPA (netupitant/palonosetron) across multiple cycles of chemotherapy in breast cancer patients: A subanalysis from two phase III trialsHope S Rugo, Giorgia Rossi, Giada Rizzi, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|April 2, 2020
Biosimilar Pegfilgrastim: Improving Access and Optimising Practice to Supportive Care that Enables CurePaul Cornes, Pere Gascon, Arnold G Vulto, et al.
Current Opinion in Obstetrics & Gynecology|May 7, 2004
Chemotherapy for metastatic breast cancerLaura Biganzoli, Alessandro Minisini, Matti Aapro, et al.
Critical Reviews in Oncology/Hematology|May 14, 2005
Drug-drug interactions in oncology: why are they important and can they be minimized?Peter Blower, Ronald de Wit, Susan Goodin, et al.
The Oncologist|September 5, 2020
ASCO 2020: The Geriatric Assessment Comes of AgeEnrique Soto-Perez-de-Celis, Matti Aapro, Hyman Muss
Critical Reviews in Oncology/Hematology|September 9, 2008
The medical treatment of metastatic renal cell cancer in the elderly: position paper of a SIOG TaskforceJoaquim Bellmunt, Sylvie Négrier, Bernard Escudier, et al.
Cancer Reports (Hoboken, N.J.)|July 31, 2020
Oncologist perspectives on chemotherapy-induced nausea and vomiting (CINV) management and outcomes: A quantitative market research-based surveyMatti Aapro, Pierfrancesco Ruffo, Roger Panteri, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|August 24, 2019
Extrapolation in Practice: Lessons from 10 Years with Biosimilar FilgrastimPere Gascon, Andriy Krendyukov, Nicola Mathieson, et al.
Therapeutic Advances in Medical Oncology|May 1, 2018
Development and 10-year history of a biosimilar: the example of Binocrit<sup>®</sup>Matti Aapro, Andriy Krendyukov, Nadja Höbel, et al.
Critical Reviews in Oncology/Hematology|November 27, 2013
Epidemiological and nonclinical studies investigating effects of iron in carcinogenesis--a critical reviewYves Beguin, Matti Aapro, Heinz Ludwig, et al.
Pageof 24

Showing results (81-90 of 237) with videos related to

Sort By:
Pageof 24
Breast (Edinburgh, Scotland)|March 13, 2017
Efficacy of NEPA (netupitant/palonosetron) across multiple cycles of chemotherapy in breast cancer patients: A subanalysis from two phase III trialsHope S Rugo, Giorgia Rossi, Giada Rizzi, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|April 2, 2020
Biosimilar Pegfilgrastim: Improving Access and Optimising Practice to Supportive Care that Enables CurePaul Cornes, Pere Gascon, Arnold G Vulto, et al.
Current Opinion in Obstetrics & Gynecology|May 7, 2004
Chemotherapy for metastatic breast cancerLaura Biganzoli, Alessandro Minisini, Matti Aapro, et al.
Critical Reviews in Oncology/Hematology|May 14, 2005
Drug-drug interactions in oncology: why are they important and can they be minimized?Peter Blower, Ronald de Wit, Susan Goodin, et al.
The Oncologist|September 5, 2020
ASCO 2020: The Geriatric Assessment Comes of AgeEnrique Soto-Perez-de-Celis, Matti Aapro, Hyman Muss
Critical Reviews in Oncology/Hematology|September 9, 2008
The medical treatment of metastatic renal cell cancer in the elderly: position paper of a SIOG TaskforceJoaquim Bellmunt, Sylvie Négrier, Bernard Escudier, et al.
Cancer Reports (Hoboken, N.J.)|July 31, 2020
Oncologist perspectives on chemotherapy-induced nausea and vomiting (CINV) management and outcomes: A quantitative market research-based surveyMatti Aapro, Pierfrancesco Ruffo, Roger Panteri, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|August 24, 2019
Extrapolation in Practice: Lessons from 10 Years with Biosimilar FilgrastimPere Gascon, Andriy Krendyukov, Nicola Mathieson, et al.
Therapeutic Advances in Medical Oncology|May 1, 2018
Development and 10-year history of a biosimilar: the example of Binocrit<sup>®</sup>Matti Aapro, Andriy Krendyukov, Nadja Höbel, et al.
Critical Reviews in Oncology/Hematology|November 27, 2013
Epidemiological and nonclinical studies investigating effects of iron in carcinogenesis--a critical reviewYves Beguin, Matti Aapro, Heinz Ludwig, et al.
Pageof 24